The Belgian Early Warning System Drugs (BEWSD) at the Scientific Institute of Public Health (WIV-ISP) would like to report the identification and analysis of several highly dosed ecstasy tablets.
One tablet was analyzed by the NICC-INCC (dr. Vanderlinden), the other tablets were analyzed by the Ghent University Toxicology laboratory (prof. Stove).
All tablet characteristics including MDMA dosage per tablet can be found in the table below.
One tablet did not contain MDMA but 2C-B, a mild hallucinogenic substance, with unknown dosage.
The BEWSD would like to draw your attention specifically to those results.
We take this opportunity to remind you that the majority of ecstasy tablets currently circulating are highly dosed, sometimes containing dosages of up to 300 mg MDMA base
The amount of MDMA present in an ecstasy tablet can only be determined using laboratory analysis.
Symptoms of an MDMA overdose are characterised by heavy sweating, tremor, dry mouth, nausea, vomiting, elevated blood pressure and heart rate, paranoia and hyperthermia.
In severe cases a serotonin syndrome can occur, resulting in an often fatal hyperthermia. Overdose treatment is symptomatic.
Please inform your networks.